FEED ENvue Medical, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1326706 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-17.7%
TTM net income YoY-154.6%
TTM EPS YoY72.9%
Revenue 3-yr CAGR44.2%
Net income 3-yr CAGR—
Margins
Gross margin-26.1%
Operating margin-1,362.7%
Net margin-1,093.6%
FCF margin-609.8%
EBITDA margin-1,313.3%
Returns
ROE-59.1%
ROA-46.9%
ROIC (approx.)-62.7%
Asset turnover0.04x
Leverage & solvency
Liabilities / assets19.9%
Debt / equity0.00x
Current ratio0.66x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.55x
Accruals ratio-20.9%
Payout ratio—
Capex / revenue4.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.55M | $2.56M | $2.28M | $752,000 | $1.70M |
| Cost of revenue | $2.40M | $1.05M | $746,000 | $585,000 | $925,000 |
| Gross profit | $153,000 | $1.51M | $1.54M | $167,000 | $770,000 |
| R&D expense | $1.76M | $909,000 | $185,000 | $283,000 | $293,000 |
| SG&A expense | $7.63M | $3.46M | $3.92M | $3.93M | $5.06M |
| Operating income | -$22.89M | -$3.58M | -$3.44M | -$5.01M | -$5.68M |
| Interest expense | — | $135,000 | $135,000 | $347,000 | — |
| Pretax income | -$18.49M | -$3.69M | -$3.68M | -$5.41M | -$14.25M |
| Income tax | -$307,000 | $19,000 | $29,000 | $35,000 | $32,000 |
| Net income | -$18.18M | -$3.71M | -$3.71M | -$5.45M | -$14.28M |
| EBITDA | -$21.99M | -$3.58M | -$3.44M | -$5.01M | -$5.68M |
| EPS (basic) | -26.69 | -137.30 | -23.32 | -3.84 | -11.35 |
| EPS (diluted) | -26.69 | -137.30 | -23.32 | -3.84 | -0.57 |
| Weighted avg. shares (diluted) | 628,534 | 26,985 | 159,105 | 1.42M | 25.16M |
| Balance sheet | |||||
| Cash & equivalents | $4.22M | $752,000 | $3.28M | $2.71M | $7.74M |
| Receivables | $289,000 | $98,000 | $318,000 | $9,000 | $200,000 |
| Inventory | $2.34M | $2.19M | $2.73M | $2.17M | $175,000 |
| Current assets | $7.27M | $3.33M | $6.49M | $5.61M | $8.34M |
| PP&E, net | $119,000 | $9,000 | $7,000 | $7,000 | $5,000 |
| Goodwill | $29.08M | — | — | — | — |
| Intangibles | $4.38M | — | — | — | — |
| Total assets | $41.12M | $3.63M | $6.67M | $5.88M | $8.62M |
| Current liabilities | $6.66M | $2.72M | $2.45M | $2.32M | $1.90M |
| Total liabilities | $7.63M | $3.00M | $2.69M | $2.65M | $2.31M |
| Shareholders' equity | $33.50M | $627,000 | $3.99M | $3.23M | $6.31M |
| Shares outstanding | 1.10M | 37,894 | 186,028 | 1.64M | 1.40M |
| Cash flow statement | |||||
| Operating cash flow | -$9.37M | -$2.52M | -$3.60M | -$7.04M | -$4.37M |
| Capital expenditure | $60,000 | $3,000 | $1,000 | $3,000 | $3,000 |
| Free cash flow | -$9.43M | -$2.52M | -$3.60M | -$7.04M | -$4.37M |
| Investing cash flow | $88,000 | -$3,000 | -$1,000 | -$3,000 | -$3,000 |
| Financing cash flow | $12.79M | $1,000 | $4.22M | $2.09M | $4.58M |
| Depreciation & amortization | $897,000 | $1,000 | $1,000 | $1,000 | $2,000 |
| Stock-based compensation | — | $356,000 | $293,000 | $354,000 | $382,000 |
Free plan shows the latest 5 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.